This document is an excerpt from the EUR-Lex website
Document 31989L0343
National transposition measures communicated by the Member States concerning:
Richtlijn 89/343/EEG van de Raad van 3 mei 1989 tot uitbreiding van de werkingssfeer van de Richtlijnen 65/65/EEG en 75/319/EEG en tot vaststelling van bijkomende bepalingen voor radiofarmaceutica
OJ L 142, 25/05/1989, p. 16–18
(ES, DA, DE, EL, EN, FR, IT, NL, PT) This document has been published in a special edition(s)
(FI, SV)
The member states bear sole responsibility for all information on this site provided by them on the transposition of EU law into national law. This does not, however, prejudice the results of the verification by the Commission of the completeness and correctness of the transposition of EU law into national law as formally notified to it by the member states. The collection National transposition measures is updated weekly.
Arrêté Royal du 31/12/1992. Moniteur belge du 27/12/1992 Page 1459
Décision ministérielle numéro A6/3114 du 11/03/1992. FEK numéro 220 du 02/04/1992 Page 2061
Décision ministérielle numéro Y6a/882/93 du 11/08/1993. FEK numéro 690 du 08/09/1993 Page 7301
Besluit van 15/07/1993 radiofarmaceutische produkten, Staatsblad nummer 493 van 1993 bladzijde 1
Lääkelaki (395/87) 10/04/1987, muutos (1046/93) 26/11/1993
Läkemedelslag, Svensk författningssamling SFS) 1992:859
Läkemedelsförordning, Svensk författningssamling SFS) 1992:1752
The Medicines Act 1968 (Amendment) Regulations 1992. Statutory Instruments number 604 of 1992
The Medicines (Labelling) Amendment Regulations 1992. Statutory Instruments number 3273 of 1992
The Medicines (Leaflets) Amendment Regulations 1992. Statutory Instruments number 3274 of 1992